SCHEMBL12874162

SCHEMBL12874162

CCCCCCCCCCc1sc2c(sc3c2sc2c3sc3c4sc5c(CCCCCCCCCC)c(CCCCCCCCCC)sc5c4sc32)c1CCCCCCCCCC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 5/20 0.37
ALDH1A1 P00352 2/20 0.36
DNM1 Q05193 1/20 0.34
TYMP P19971 2/20 0.33
TSHR P16473 1/20 0.33
THRB P10828 1/20 0.33
ALOX5 P09917 1/20 0.32
ESR1 P03372 2/20 0.31
ADRA2A P08913 2/20 0.31
ADORA3 P0DMS8 2/20 0.31
TACR2 P21452 2/20 0.31
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
SLC6A3 Q01959 2/20 0.31
PTGS2 P35354 2/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
SHBG P04278 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12704406 1.00 GPR35 (0.37) GPR35ALDH1A1DNM1TYMPTSHR
SCHEMBL16139815 0.84 GPR35 (0.43) GPR35TSHRALOX5TP53CYP3A4
SCHEMBL12873847 0.84 GPR35 (0.35) GPR35ALOX5PTGS2
SCHEMBL12704412 0.83 GPR35 (0.54) GPR35
SCHEMBL1157428 0.83 GPR35 (0.54) GPR35
SCHEMBL991441 0.82 ALDH1A1 (0.41) GPR35ALDH1A1TYMPTSHRTHRB
SCHEMBL12874160 0.82 GPR35 (0.35) GPR35ALOX5PTGS2
SCHEMBL12709450 0.81 GPR35 (0.38) GPR35ALDH1A1DNM1TYMPTSHR
SCHEMBL12017133 0.81 GPR35 (0.38) GPR35ALDH1A1DNM1TYMPTSHR
SCHEMBL1157128 0.81 GPR35 (0.56) GPR35ALDH1A1ESR1ADRA2AADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773646-B1 CONJUGATED FUSED THIOPHENES, METHODS OF MAKING CONJUGATED FUSED THIOPHENES, AND USES THEREOF CORNING INC (US) 2016-06-15 EP disclosed
EP-1799688-B1 FUSED THIOPHENES, METHODS FOR MAKING FUSED THIOPHENES, AND USES THEREOF CORNING INC (US) 2013-06-19 EP disclosed
US-8349998-B2 Fused thiophenes, methods for making fused thiophenes, and uses thereof CORNING INCORPORATED (US) 2013-01-08 US disclosed
US-7893191-B2 Fused thiophenes, methods for making fused thiophenes, and uses thereof CORNING INCORPORATED (US) 2011-02-22 US disclosed
US-20110040042-A1 FUSED THIOPHENES, METHODS FOR MAKING FUSED THIOPHENES, AND USES THEREOF HE MINGQIAN 2011-02-17 US disclosed
US-7705108-B2 Fused thiophenes, methods for making fused thiophenes, and uses thereof CORNING INCORPORATED (US) 2010-04-27 US disclosed
US-20100010237-A1 FUSED THIOPHENES, METHODS FOR MAKING FUSED THIOPHENES, AND USES THEREOF HE MINGQIAN 2010-01-14 US disclosed
US-20070265418-A1 Fused Thiophenes, Methods for Making Fused Thiophenes, and Uses Thereof CORNING INCORPORATED 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110040042-A1 FUSED THIOPHENES, METHODS FOR MAKING FUSED THIOPHENES, AND USES THEREOF TPMT, TST, TYMP GPR35 4429/4885ALDH1A1 2135/4885DNM1 1780/4885
US-20100010237-A1 FUSED THIOPHENES, METHODS FOR MAKING FUSED THIOPHENES, AND USES THEREOF TPMT, TST, TYMP GPR35 4520/4885ALDH1A1 2157/4885DNM1 1856/4885
US-20070265418-A1 Fused Thiophenes, Methods for Making Fused Thiophenes, and Uses Thereof TPMT, TST, TYMP GPR35 4429/4885ALDH1A1 2135/4885DNM1 1780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.